Biaryl ligands

US9994599B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9994599-B2
Application numberUS-201415021053-A
CountryUS
Kind codeB2
Filing dateSep 12, 2014
Priority dateSep 13, 2013
Publication dateJun 12, 2018
Grant dateJun 12, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the present disclosure provide for biaryl ligands (also referred to herein as “biaryl compound”), biaryl complexes, methods of making biaryl compounds, methods of making single enantiomers of these biaryl compounds, methods of use (e.g., catalysis) and the like.

First claim

Opening claim text (preview).

At least the following is claimed: 1. A The composition comprising a single biaryl enantiomer having the following structure: wherein each of the R 5 groups is independently selected from the group consisting of: hydrogen, a halogen group, a cyclic or linear, alkyl group, an aryl group, a —OR group, and a —SR group, wherein each of R group is independently selected from the group consisting of: hydrogen, a cyclic or linear alkyl group, and an aryl group, wherein n is 1 to 5, wherein X is C or SO 2 , wherein each R 6 and R 7 group is independently selected from the group consisting of: hydrogen, a cyclic or linear alkyl group, and an aryl group, wherein when X is SO 2 , R 6 and R 7 are not present; wherein each of Q1, Q2, Q3, Q4, and Q5 is independently selected from the group consisting of C, N, O, and S, wherein at least one of Q1, Q2, Q3, Q4, and Q5 is selected from the group consisting of N, O, and S, wherein R 1 and R 2 are independently selected from the group consisting of: hydrogen, a halogen group, a cyclic or linear, alkyl group, an aryl group, a —OR group, and a —SR group; and wherein each of the R 4 groups is independently selected from the group consisting of: hydrogen, a halogen group, a cyclic or linear, alkyl group, an aryl group, a —OR group, and a —SR group, wherein m is 1 to 5, wherein each of the R 3 groups is independently selected from the group consisting of: hydrogen, a cyclic or linear, alkyl group, an alkoxide, a phenoxide, an aryl group, and a substituted amine. 2. The composition of claim 1 , wherein each R 5 is halogen, wherein two of Q1, Q2, Q3, Q4, and Q5 are N, wherein X is C, and wherein each R 3 is an aryl group. 3. The composition of claim 2 , wherein Q2 and Q5 are N. 4. The composition of claim 2 , wherein each R 3 is a phenyl group. 5. The composition of claim 2 , wherein each R 5 is fluorine. 6. A composition comprising: a single biaryl enantiomer having the following structure: wherein each of the R 5 groups is independently selected from the group consisting of: hydrogen, a halogen group, a cyclic or linear, alkyl group, an aryl group, a —OR group, and a —SR group, wherein each of R group is independently selected from the group consisting of: hydrogen, a cyclic or linear alkyl group, and an aryl group, wherein n is 1 to 5, wherein X is C or SO 2 , wherein each R 6 and R 7 group is independently selected from the group consisting of: hydrogen, a cyclic or linear, alkyl group, and an aryl group, wherein when X is SO 2 , R 6 and R 7 are not present, wherein R 1 and R 2 are independently selected from the group consisting of: hydrogen, a halogen group, a cyclic or linear, alkyl group, an aryl group, a —OR group, and a —SR group, wherein each of the R 4 groups is independently selected from the group consisting of: hydrogen, a halogen group, a cyclic or linear, alkyl group, an aryl group, a —OR group, and a —SR group, wherein m is 1 to 5, and wherein each of the R 3 groups is independently selected from the group consisting of: hydrogen, a cyclic or linear, alkyl group, an alkoxide, a phenoxide, an aryl group, and a substituted amine. 7. The composition of claim 6 , wherein X is C, wherein each R 3 is a phenyl group, and wherein each R 5 is fluorine. 8. A composition comprising: a structure selected from the group consisting of:

Assignees

Inventors

Classifications

  • C07D233/20Primary

    with substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title

  • C07F9/6506Primary

    having the nitrogen atoms in positions 1 and 3 · CPC title

  • Oxygen atoms · CPC title

  • by substitution of other functional groups · CPC title

  • Syntheses without formation of a Si-C bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9994599B2 cover?
Embodiments of the present disclosure provide for biaryl ligands (also referred to herein as “biaryl compound”), biaryl complexes, methods of making biaryl compounds, methods of making single enantiomers of these biaryl compounds, methods of use (e.g., catalysis) and the like.
Who is the assignee on this patent?
Univ Florida
What technology area does this patent fall under?
Primary CPC classification C07D233/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).